CompletedPhase 4

Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

Mexico334 participantsStarted 2007-01

Plain-language summary

The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 18 years, both genders, without any previous treatment with statins or other lipid lowering drugs for at least 6 months * With elevated triglycerides above 200 and below 800mg/dl and willing to follow all study procedures including assisting to clinics, fasting before blood samples and signing a written consent Exclusion Criteria: * High levels of low-density lipoprotein cholesterol (LDL-C) * Unstable cardiovascular condition or awaiting a myocardial revascularization * Congestive cardiac failure * Uncontrolled diabetes * Cancer * Uncontrolled hypothyroidism * Familial hypercholesterolemia * Liver/muscle disease * Pregnancy * Other

What they're measuring

Change (Reduction) in Triglycerides Levels From Baseline to End of Treatment (Week 8)

Timeframe: 8 weeks

Trial details

NCT IDNCT00473655

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-02

Results submitted2010-05-10

View on ClinicalTrials.gov More Hypertriglyceridemia trials